It was actually a really bad deal for ACHN. They are down a considerable amount today.
- Forums
- ASX - By Stock
- BLT
- J&J pays 1.1B for Achillion Hep C line
J&J pays 1.1B for Achillion Hep C line, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)